DT
HealthMore in Health→
Existing drug combinations show new promise for treatment-resistant depression
Key Takeaways
- Researchers reviewed 26 randomized controlled trials of intravenous ketamine.
- Ketamine outperformed placebo over the short term and appeared comparable to esketamine.
- Both ketamine and esketamine were reported to rapidly reduce suicidal impulses in acute cases.
DE
DT Editorial Team··via medicalxpress.com